These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9528560)

  • 1. Trick or treatment.
    Clark G
    Nurs Times; 1998 Feb 11-17; 94(6):12-3. PubMed ID: 9528560
    [No Abstract]   [Full Text] [Related]  

  • 2. Heroin reaches the well-to-do population.
    Rosenker DC
    Behav Healthc Tomorrow; 2002 Oct; 11(5):SR28-30. PubMed ID: 12360788
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment.
    Astals M; Domingo-Salvany A; Buenaventura CC; Tato J; Vazquez JM; Martín-Santos R; Torrens M
    Subst Use Misuse; 2008; 43(5):612-32. PubMed ID: 18393080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes and predictors of change in the physical health status of heroin users over 24 months.
    Williamson A; Darke S; Ross J; Teesson M
    Addiction; 2009 Mar; 104(3):465-70. PubMed ID: 19207357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heroin dependence.
    Brown R
    WMJ; 2004; 103(4):20-6. PubMed ID: 15481866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heroin treatment demand in South Africa: trends from two large metropolitan sites (January 1997-December 2003).
    Parry CD; Plüddemann A; Myers BJ
    Drug Alcohol Rev; 2005 Sep; 24(5):419-23. PubMed ID: 16298836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population.
    Bargagli AM; Faggiano F; Amato L; Salamina G; Davoli M; Mathis F; Cuomo L; Schifano P; Burroni P; Perucci CA;
    Subst Use Misuse; 2006; 41(14):1861-79. PubMed ID: 17162594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The costs and consequences of three policy options for reducing heroin dependency.
    Moore TJ; Ritter A; Caulkins JP
    Drug Alcohol Rev; 2007 Jul; 26(4):369-78. PubMed ID: 17564872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 10-year follow-up study on the health status of heroin addicts based on official registers.
    Sánchez-Carbonell X; Vilaregut A
    Addiction; 2001 Dec; 96(12):1777-86. PubMed ID: 11784470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
    J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.
    Dobler-Mikola A; Hättenschwiler J; Meili D; Beck T; Böni E; Modestin J
    J Subst Abuse Treat; 2005 Dec; 29(4):259-65. PubMed ID: 16311178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young heroin users in Baltimore: a qualitative study.
    Gandhi DH; Kavanagh GJ; Jaffe JH
    Am J Drug Alcohol Abuse; 2006; 32(2):177-88. PubMed ID: 16595322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
    Davoli M; Bargagli AM; Perucci CA; Schifano P; Belleudi V; Hickman M; Salamina G; Diecidue R; Vigna-Taglianti F; Faggiano F;
    Addiction; 2007 Dec; 102(12):1954-9. PubMed ID: 18031430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. School-based substance abuse prevention: a public health perspective.
    Thomas A; Davies S
    N C Med J; 2008; 69(6):502-4. PubMed ID: 19256195
    [No Abstract]   [Full Text] [Related]  

  • 17. Rhabdomyolysis and brain ischemic stroke in a heroin-dependent male. Invited comment.
    Somala RK
    Acta Psychiatr Scand; 2009 Jul; 120(1):80-1. PubMed ID: 19519677
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription naloxone: a novel approach to heroin overdose prevention.
    Sporer KA; Kral AH
    Ann Emerg Med; 2007 Feb; 49(2):172-7. PubMed ID: 17141138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United kingdom.
    Metrebian N; Mott J; Carnwath Z; Carnwath T; Stimson GV; Sell L
    Eur Addict Res; 2007; 13(3):144-7. PubMed ID: 17570910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.